RxDoctor Payments Data

William Reno, MD

Plastic Surgery · Hattiesburg, MSNPI 1861580557

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,499 of the $3,683 with a category attached, or 67.9%. AbbVie accounts for 65.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $1,512 and has fallen 63.7% since, to $548 in 2025.

$3,683in general payments, 2019–2025

Across 138 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Smith+Nephew$177
  • Galderma Laboratories, L.p.$175
  • Revance Therapeutics, Inc.$144
  • Integra Lifesciences Corporation$99
  • Convatec Inc.$87
  • plus $578 from 20 others

What the payments were for

  • Food & beverage$2,49968%
  • Gifts$1,18432%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,683 in reported general payments places this provider in the 70th percentile of 25 plastic surgery providers in Mississippi.

See all plastic surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$82,726
Medicare patients
145
Services billed
445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CefuroximeCefuroxime Axetil60$697
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$348
Mupirocin21$132
Cyclobenzaprine Hcl16$56
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$33
Clonidine Hcl22$10

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Hattiesburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →